This is a revised application seeking to establish a Digestive Diseases Research Core Center to study the pathophysiology and epidemiology of diarrheal disease. The revision consists of the addition of key personnel, the deletion of 2 Core laboratories, and reduction of the number of proposed pilot/feasibility studies from 9 to 5. This CORE CENTER in DIARRHEAL DISEASES (CCDD) would bring together scientists from the Schools of Medicine, Dentistry, and Public Health at the University of North Carolina at Chapel Hill, and the Schools of Veterinary Medicine and Agriculture/Life Sciences at North Carolina State University in a unique cooperative effort to study normal gut function and its derangements which cause diarrhea. Scientists from 15 departments in these 5 schools would take part in the basic research in intestinal water and electrolyte transport, immunology/microbiology, hormones and mucosal biochemistry, and in clinical research in the epidemiology of infectious and chronic diarrhea and the treatment of inflammatory bowel disease. To facilitate and enhance this base research, the CCDD proposes to establish 3 support Core Units: 1) Administrative Core, 2) Barrier Intact Animal Facility, and 3) Biostatistics Core. To promote research into the two major subthemes which grow naturally from this collaboration (inflammatory bowel disease (IBD) and infectious diarrhea), the CCDD proposes to fund 5 pilot/feasibility studies of epidemiology and pathophysiology: 1) Pathophysiology of Cryptosporidiosis; 2) Mucus Glycoprotein Synthesis in Rotavirus Infection; 3) Epidemiology of IBD; 4) Relationship of Glandular Kallikrein to IBD; and 5) Effect of Sterile Bacterial Cell Walls on Gut Mucosal Immunity. The CCDD would also promote an understanding of diarrheal diseases through a Scientific Enrichment Program consisting of speakers and seminars. In future years of CCDD operation, a Scientific Review Committee from outside the University would critique Center activities, advise on the operation of Core Units, and select subsequent pilot/feasibility studies from applications submitted by faculty from the two campuses. These administrative and advisory components would assure that these heretofore diverse organizations are joined together by common goals which should yield significant new knowledge about diseases that cause billions of dollars of economic loss in developed nations and millions of lost lives in developing nations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
3P30DK034987-01A1S1
Application #
3102065
Study Section
(SRC)
Project Start
1985-09-01
Project End
1989-11-30
Budget Start
1986-09-01
Budget End
1986-11-30
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rolston, Vineet S; Boroujerdi, Laleh; Long, Millie D et al. (2018) The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study. Inflamm Bowel Dis 24:387-393
Eaton, Kathryn; Pirani, Ali; Snitkin, Evan S et al. (2018) Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 7:
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Palacios, Michelle; Miner, Taryn A; Frederick, Daniel R et al. (2018) Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. MBio 9:
Williamson, Ian A; Arnold, Jason W; Samsa, Leigh Ann et al. (2018) A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 6:301-319
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Evon, Donna M; Golin, Carol E; Ruffin, Rachel et al. (2018) Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot Feasibility Stud 4:92
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Herfarth, Hans; Barnes, Edward L; Valentine, John F et al. (2018) Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology 155:1098-1108.e9

Showing the most recent 10 out of 944 publications